MARKET INTRODUCTION
An aneurysm is the widening of an artery that is caused by weakness in the arterial wall. An aneurysm creates an enlargement or bulge of the artery. Although the disease does not show symptoms and is not dangerous, however, a ruptured aneurysm can life-threatening internal bleeding. It has been treated by surgical intervention techniques, where the affected portion of the blood vessel can be removed. Sometimes, the medication methods are also used that involve drugs to treat the disease.
MARKET DYNAMICS
The aneurysm therapeutics market is anticipated to grow in the forecast, owing to the increasing rate of smoking among the population, high blood pressure (hypertension), and rise in the incidence of underlying diseases that increase the risk of developing aneurysms. However, the hardening of the arteries (arteriosclerosis) is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Aneurysm Therapeutics Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of the aneurysm therapeutics market with detailed market segmentation by type, and end-user and geography. The aneurysm therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading aneurysm therapeutics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The aneurysm therapeutics market is segmented on the basis of type, and end user. On the basis of type, the market is categorized into medicine, surgical and others. Based on the end user, the market is segmented as hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry, including both qualitative and quantitative information. It provides an overview and forecast of the aneurysm therapeutics market based on various segments. It also provides market size and forecast estimates from the year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. The aneurysm therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting the aneurysm therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the aneurysm therapeutics market in these regions.
MARKET PLAYERS
The report covers key developments in the aneurysm therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from aneurysm therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for aneurysm therapeutics market in the global market. Below mentioned is the list of few companies engaged in the aneurysm therapeutics market.
The report also includes the profiles of key aneurysm therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- GENERAL ELECTRIC COMPANY
- Terumo Corporation
- JOTEC GmbH
- Cook
- Lifetech Scientific
- Lombard Medical Limited
- Cardinal Health
- Pfizer Inc.
- Medtronic
- W. L. Gore & Associates
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.